Your browser doesn't support javascript.
loading
Pharmacokinetics of Sugammadex: An Open-Label, 3-Period, Fixed-Sequence, 3-Single-Doses Study in Healthy Chinese Subjects.
Yuan, Fei; Yang, Mengjie; Chen, Weili; Chen, Hanjing; Xu, Hongrong; Li, Hui; Sheng, Lei; Li, Xuening; Ellen Wrishko, Rebecca; Joel Woolf, Eric.
Afiliação
  • Yuan F; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yang M; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen W; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen H; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu H; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li H; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sheng L; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li X; Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ellen Wrishko R; Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Joel Woolf E; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Clin Pharmacol Drug Dev ; 11(3): 333-340, 2022 03.
Article em En | MEDLINE | ID: mdl-34939354
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Povo Asiático / Sugammadex Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Povo Asiático / Sugammadex Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China